These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 29782332)

  • 1. Detection of high-risk thrombophilia with an automated, global test: the Coagulation Inhibitor Potential assay.
    Réger B; Losonczy H; Nagy Á; Péterfalvi Á; Mózes R; Pótó L; Farkas N; Kovács GL; Miseta A; Hussain A; Tóth O
    Blood Coagul Fibrinolysis; 2018 Jul; 29(5):435-441. PubMed ID: 29782332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ability of three global plasma assays to recognize thrombophilia.
    Andresen MS; Abildgaard U; Liestøl S; Sandset PM; Mowinckel MC; Ødegaard OR; Larsen ML; Diep LM
    Thromb Res; 2004; 113(6):411-7. PubMed ID: 15226097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laboratory diagnosis of hereditary thrombophilia.
    Michiels JJ; Hamulyák K
    Semin Thromb Hemost; 1998; 24(4):309-20. PubMed ID: 9763348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Danger of false negative (exclusion) or false positive (diagnosis) for 'congenital thrombophilia' in the age of anticoagulants.
    Favaloro EJ
    Clin Chem Lab Med; 2019 May; 57(6):873-882. PubMed ID: 30485173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overall haemostasis potential assays performed in thrombophilic plasma: the effect of preactivating protein C and antithrombin.
    Andresen MS; Iversen N; Abildgaard U
    Thromb Res; 2002 Dec; 108(5-6):323-8. PubMed ID: 12676193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitivity of the ProC global assay for protein C pathway abnormalities. clinical experience in 899 unselected patients with venous thromboembolism.
    Toulon P; Adda R; Perez P
    Thromb Res; 2001 Oct; 104(2):93-103. PubMed ID: 11672753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The reduced sensitivity of the ProC Global test in protein S deficient subjects reflects a reduction in the associated thrombotic risk.
    Gemmati D; Serino ML; Tognazzo S; Ongaro A; Moratelli S; Gilli G; Forini E; De Mattei M; Scapoli GL
    Blood Coagul Fibrinolysis; 2001 Dec; 12(8):691-7. PubMed ID: 11734670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical evaluation of a functional prothrombin time-based assay for identification of factor V Leiden carriers in a group of Italian patients with venous thrombosis.
    Gessoni G; Valverde S
    Blood Coagul Fibrinolysis; 2007 Oct; 18(7):603-10. PubMed ID: 17890946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uncertain thrombophilia markers.
    Franchini M; Martinelli I; Mannucci PM
    Thromb Haemost; 2016 Jan; 115(1):25-30. PubMed ID: 26271270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical aspects and laboratory problems in hereditary thrombophilia.
    Samama M; Gerotziafas G; Conard J; Horellou M; Elalamy I
    Haemostasis; 1999; 29(2-3):76-99. PubMed ID: 10629390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein C deficiency as the major cause of thrombophilias in childhood.
    Ohga S; Ishiguro A; Takahashi Y; Shima M; Taki M; Kaneko M; Fukushima K; Kang D; Hara T;
    Pediatr Int; 2013 Jun; 55(3):267-71. PubMed ID: 23521084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombophilia and unexplained pregnancy loss in Indian patients.
    Vora S; Shetty S; Salvi V; Satoskar P; Ghosh K
    Natl Med J India; 2008; 21(3):116-9. PubMed ID: 19004141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and application of an automated chromogenic thrombin generation assay that is sensitive to defects in the protein C pathway.
    Green L; Safa O; Machin SJ; Mackie IJ; Ryland K; Cohen H; Lawrie AS
    Thromb Res; 2012 Nov; 130(5):780-4. PubMed ID: 22265675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prothrombin polymorphism A19911G, factor V HR2 haplotype A4070G, and plasminogen activator-inhibitor-1 polymorphism 4G/5G and the risk of retinal vein occlusion.
    Kuhli-Hattenbach C; Hellstern P; Nägler DK; Kohnen T; Hattenbach LO
    Ophthalmic Genet; 2017; 38(5):413-417. PubMed ID: 28085526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multilaboratory testing of thrombophilia: current and past practice in Australasia as assessed through the Royal College of Pathologists of Australasia Quality Assurance Program for Hematology.
    Favaloro EJ; Bonar R; Sioufi J; Wheeler M; Low J; Aboud M; Duncan E; Smith J; Exner T; Lloyd J; Marsden K;
    Semin Thromb Hemost; 2005 Feb; 31(1):49-58. PubMed ID: 15706475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of thrombophilia detected in southern Taiwanese patients with venous thrombosis.
    Chen TY; Su WC; Tsao CJ
    Ann Hematol; 2003 Feb; 82(2):114-117. PubMed ID: 12601491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of Hereditary Thrombophilia: Performance of Protein C (PC) Testing.
    Marlar RA; Gausman JN
    Methods Mol Biol; 2017; 1646():145-151. PubMed ID: 28804825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnosis of thrombophilia based on coagulation and genetic studies].
    Bałszan-Kowalska I
    Ann Acad Med Stetin; 2002; 48():179-93. PubMed ID: 14601477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ProC global: a new automated screening assay for the evaluation of total function of the protein C system.
    Dragoni F; Tormene D; Simioni P; Arcieri P; Avvisati G; Girolami A
    Clin Appl Thromb Hemost; 2001 Oct; 7(4):351-5. PubMed ID: 11697723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of prothrombin 20210A allele and factor V Leiden mutation to thrombosis risk in thrombophilic families with other hemostatic deficiencies.
    Tirado I; Mateo J; Soria JM; Oliver A; Borrell M; Coll I; Vallvé C; Souto JC; Martínez-Sánchez E; Fontcuberta J
    Haematologica; 2001 Nov; 86(11):1200-8. PubMed ID: 11694407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.